MICHELLE AULD: Open Payments
NPI 1336699941 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 25 payments from 9 companies in 2025. Trend: 2023 $1,177 · 2024 $1,180 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $233 |
| Otsuka America Pharmaceutical, Inc. | 3 | $132 |
| MERZ NORTH AMERICA, INC. | 1 | $128 |
| Galderma Laboratories, L.P. | 2 | $125 |
| PFIZER INC. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REXULTI, Xeomin, VRAYLAR, QULIPTA, UBRELVY, XIFAXAN, SPRAVATO, FREESTYLE LIBRE 3.
Industry payments across AR — which companies pay providers there.
